Form D · Other Health Care
Power Life Sciences, Inc.
San Francisco, CA · CIK 0001942846
Offering snapshot reported Dec 22, 2023 · SEC filing
- Reported sold
- $11.9M Offering amount: $12M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 7, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 22, 2023 | Initial | $11,934,978 | No comparison | 14 | SEC filing |
| Aug 22, 2022 | Initial | $6,909,993 | No comparison | 48 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-500558
Includes shares of preferred stock issued pursuant to the cancellation of SAFE indebtedness in the amount of $35,000
Source: Form D, filed Dec 22, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Gill | Director, Executive |
| Brandon Li | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
461 2 Nd St Unit C131
San Francisco, CA, 94107
San Francisco, CA, 94107